Ginkgo Biloba for Tinnitus: Does It Work?

Ginkgo biloba is one of the most widely used herbal supplements globally and historically one of the most studied natural compounds for tinnitus. Yet its evidence base for tinnitus is more nuanced than either its proponents or critics typically acknowledge. The story is not a simple yes or no. It depends critically on the extract formulation used, the dose, the patient population, and the specific type of tinnitus being treated.

What Makes EGb 761 Different From Generic Ginkgo

Not all ginkgo biloba extracts are equivalent. EGb 761 (also marketed as Tanakan, Tebonin, and Rökan) is a precisely standardized extract containing 24% flavone glycosides (including quercetin, kaempferol, and isorhamnetin) and 6% terpene lactones (ginkgolide A, B, C, and bilobalide). These constituents determine the pharmacological activity of the extract. Generic "ginkgo supplements" sold in health stores vary enormously in their actual constituent concentrations and may contain as little as 5-10% of the claimed active compounds in some analyses. This means that studies using EGb 761 at specific doses cannot be extrapolated to generic ginkgo products, and trials showing negative results with underdosed or non-standardized extracts do not necessarily reflect EGb 761's potential.

The Cochrane Review: What It Actually Found

A 2013 Cochrane systematic review on ginkgo biloba for tinnitus concluded that there was no reliable evidence that ginkgo is effective for tinnitus. This conclusion was widely cited as definitively disproving ginkgo's efficacy. However, a closer reading reveals important caveats. The review included trials using widely varying doses (40-240 mg/day), variable extract standardization, diverse tinnitus populations (ranging from acute to chronic, from peripheral to central causes), and short follow-up periods. When the review authors examined only the higher-quality trials using standardized EGb 761, the results were more favorable. The negative conclusion reflected the overall evidence pool, heavily diluted by studies using inadequate doses of non-standardized extracts.

Subsequent to the Cochrane review, several higher-quality trials specifically examining EGb 761 at 240 mg/day have shown significant improvements. A multicenter randomized controlled trial published in the International Journal of Clinical Pharmacology and Therapeutics found that EGb 761 at 240 mg/day significantly improved tinnitus severity and tinnitus-related annoyance scores compared to placebo over 12 weeks.

Mechanisms: How Ginkgo Could Help Tinnitus

EGb 761 acts through several mechanisms potentially relevant to tinnitus. First, it is a potent platelet activating factor (PAF) antagonist. PAF promotes platelet aggregation and microthrombus formation in small vessels. Inhibiting PAF improves microcirculatory flow in the cochlea, which receives blood from a single end-artery with no collateral circulation, making it uniquely vulnerable to microvascular compromise. Second, flavone glycosides in EGb 761 scavenge reactive oxygen species in cochlear tissues, protecting residual hair cells from ongoing oxidative damage. Third, ginkgolides and bilobalide modulate GABA-A receptor activity in the central auditory pathway, potentially reducing the aberrant neural oscillation that characterizes central tinnitus. Fourth, EGb 761 improves hemorheological parameters (blood viscosity, red cell deformability) that affect cochlear perfusion.

Who Is Most Likely to Benefit

Clinical evidence and mechanistic reasoning point to specific subpopulations who are most likely to respond to ginkgo EGb 761. Patients with tinnitus associated with cerebrovascular insufficiency, atherosclerosis, or metabolic syndrome (conditions affecting cochlear blood flow) have the strongest rationale for treatment. Patients with Meniere's disease, where endolymphatic hydrops affects cochlear perfusion, represent another likely responder group. Tinnitus of sudden onset accompanying a sudden hearing loss episode may have a vascular component responsive to ginkgo. In contrast, patients with pure noise-induced cochlear damage without vascular compromise may benefit less.

Dose and Duration

The effective dose for EGb 761 is 240 mg/day, either as a single 240 mg dose or as two 120 mg doses. Lower doses used in negative trials (120 mg/day and below) appear insufficient to achieve meaningful plasma concentrations of active constituents. Treatment duration should be at least 8-12 weeks before evaluating response; short-term trials of 4-6 weeks may be insufficient to see benefit. EGb 761 should be taken consistently (same time daily) with food to reduce mild gastrointestinal side effects and to improve absorption of the lipophilic terpene lactones.

Safety and Interactions

EGb 761 has mild antiplatelet effects and should be used with caution (and under medical supervision) by patients taking anticoagulants (warfarin), antiplatelet drugs (clopidogrel, aspirin), or before any surgical procedures. It is generally well tolerated at 240 mg/day with headache, mild gastrointestinal upset, and dizziness as the most common reported side effects. Epilepsy patients should avoid ginkgo, as several case reports associate it with lowered seizure threshold.

FAQ

Q: Can I use regular ginkgo supplements from a health food store for tinnitus?

The positive evidence for tinnitus is specifically tied to EGb 761, a standardized extract. Generic ginkgo supplements have variable potency and may not deliver effective concentrations of active constituents. Look for products specifically identifying EGb 761 on the label with 24% flavone glycosides and 6% terpene lactones.

Q: How long before I know if ginkgo is working for my tinnitus?

Most positive trials used at least 12 weeks of treatment. Some patients notice gradual improvement within 4-6 weeks, while others require the full course. If there is no subjective improvement after 3 months of consistent EGb 761 at 240 mg/day, a response is unlikely.

Q: Can I take ginkgo with other tinnitus supplements like zinc and melatonin?

Yes. Ginkgo, zinc, and melatonin act through different mechanisms and their combination is rational for tinnitus patients. There are no significant pharmacokinetic interactions between these three supplements.

Track your supplements in Optimize.